Glycoengineering of Chinese hamster ovary cells for enhanced erythropoietin N-glycan branching and sialylation

Bojiao Yin, Yuan Gao, Cheng yu Chung, Shuang Yang, Emily Blake, Mark C. Stuczynski, Juechun Tang, Helene F. Kildegaard, Mikael R. Andersen, Hui Zhang, Michael J. Betenbaugh

Research output: Contribution to journalArticle

Abstract

Sialic acid, a terminal residue on complex N-glycans, and branching or antennarity can play key roles in both the biological activity and circulatory lifetime of recombinant glycoproteins of therapeutic interest. In order to examine the impact of glycosyltransferase expression on the N-glycosylation of recombinant erythropoietin (rEPO), a human α2,6-sialyltransferase (ST6Gal1) was expressed in Chinese hamster ovary (CHO-K1) cells. Sialylation increased on both EPO and CHO cellular proteins as observed by SNA lectin analysis, and HPLC profiling revealed that the sialic acid content of total glycans on EPO increased by 26%. The increase in sialic acid content was further verified by detailed profiling of the N-glycan structures using mass spectra (MS) analysis. In order to enhance antennarity/branching, UDP-N-acetylglucosamine: α-1,3-D-mannoside β1,4-N-acetylglucosaminyltransferase (GnTIV/Mgat4) and UDP-N-acetylglucosamine:α-1,6-D-mannoside β1,6-N-acetylglucosaminyltransferase (GnTV/Mgat5), was incorporated into CHO-K1 together with ST6Gal1. Tri- and tetraantennary N-glycans represented approximately 92% of the total N-glycans on the resulting EPO as measured using MS analysis. Furthermore, sialic acid content of rEPO from these engineered cells was increased ∼45% higher with tetra-sialylation accounting for ∼10% of total sugar chains compared to ∼3% for the wild-type parental CHO-K1. In this way, coordinated overexpression of these three glycosyltransferases for the first time in model CHO-K1 cell lines provides a mean for enhancing both N-glycan branching complexity and sialylation with opportunities to generate tailored complex N-glycan structures on therapeutic glycoproteins in the future.

Original languageEnglish (US)
Pages (from-to)2343-2351
Number of pages9
JournalBiotechnology and Bioengineering
Volume112
Issue number11
DOIs
StatePublished - Nov 1 2015

Fingerprint

Erythropoietin
Cricetulus
Polysaccharides
Ovary
Cells
Glycoproteins
N-Acetylneuraminic Acid
Acids
Spectrum analysis
Uridine Diphosphate N-Acetylglucosamine
Mannosides
Glycosyltransferases
Uridine Diphosphate
Glycosylation
Acetylglucosamine
CHO Cells
Bioactivity
Sugars
Mass Spectrometry
Sialyltransferases

Keywords

  • CHO
  • Erythropoietin
  • GNTIV/Mgat4
  • GNTV/Mgat5
  • N-glycosylation
  • Sialic acid

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Applied Microbiology and Biotechnology

Cite this

Yin, B., Gao, Y., Chung, C. Y., Yang, S., Blake, E., Stuczynski, M. C., ... Betenbaugh, M. J. (2015). Glycoengineering of Chinese hamster ovary cells for enhanced erythropoietin N-glycan branching and sialylation. Biotechnology and Bioengineering, 112(11), 2343-2351. https://doi.org/10.1002/bit.25650

Glycoengineering of Chinese hamster ovary cells for enhanced erythropoietin N-glycan branching and sialylation. / Yin, Bojiao; Gao, Yuan; Chung, Cheng yu; Yang, Shuang; Blake, Emily; Stuczynski, Mark C.; Tang, Juechun; Kildegaard, Helene F.; Andersen, Mikael R.; Zhang, Hui; Betenbaugh, Michael J.

In: Biotechnology and Bioengineering, Vol. 112, No. 11, 01.11.2015, p. 2343-2351.

Research output: Contribution to journalArticle

Yin, B, Gao, Y, Chung, CY, Yang, S, Blake, E, Stuczynski, MC, Tang, J, Kildegaard, HF, Andersen, MR, Zhang, H & Betenbaugh, MJ 2015, 'Glycoengineering of Chinese hamster ovary cells for enhanced erythropoietin N-glycan branching and sialylation', Biotechnology and Bioengineering, vol. 112, no. 11, pp. 2343-2351. https://doi.org/10.1002/bit.25650
Yin, Bojiao ; Gao, Yuan ; Chung, Cheng yu ; Yang, Shuang ; Blake, Emily ; Stuczynski, Mark C. ; Tang, Juechun ; Kildegaard, Helene F. ; Andersen, Mikael R. ; Zhang, Hui ; Betenbaugh, Michael J. / Glycoengineering of Chinese hamster ovary cells for enhanced erythropoietin N-glycan branching and sialylation. In: Biotechnology and Bioengineering. 2015 ; Vol. 112, No. 11. pp. 2343-2351.
@article{3ed2a5e6a28c4ab9b1306eecd1e75598,
title = "Glycoengineering of Chinese hamster ovary cells for enhanced erythropoietin N-glycan branching and sialylation",
abstract = "Sialic acid, a terminal residue on complex N-glycans, and branching or antennarity can play key roles in both the biological activity and circulatory lifetime of recombinant glycoproteins of therapeutic interest. In order to examine the impact of glycosyltransferase expression on the N-glycosylation of recombinant erythropoietin (rEPO), a human α2,6-sialyltransferase (ST6Gal1) was expressed in Chinese hamster ovary (CHO-K1) cells. Sialylation increased on both EPO and CHO cellular proteins as observed by SNA lectin analysis, and HPLC profiling revealed that the sialic acid content of total glycans on EPO increased by 26{\%}. The increase in sialic acid content was further verified by detailed profiling of the N-glycan structures using mass spectra (MS) analysis. In order to enhance antennarity/branching, UDP-N-acetylglucosamine: α-1,3-D-mannoside β1,4-N-acetylglucosaminyltransferase (GnTIV/Mgat4) and UDP-N-acetylglucosamine:α-1,6-D-mannoside β1,6-N-acetylglucosaminyltransferase (GnTV/Mgat5), was incorporated into CHO-K1 together with ST6Gal1. Tri- and tetraantennary N-glycans represented approximately 92{\%} of the total N-glycans on the resulting EPO as measured using MS analysis. Furthermore, sialic acid content of rEPO from these engineered cells was increased ∼45{\%} higher with tetra-sialylation accounting for ∼10{\%} of total sugar chains compared to ∼3{\%} for the wild-type parental CHO-K1. In this way, coordinated overexpression of these three glycosyltransferases for the first time in model CHO-K1 cell lines provides a mean for enhancing both N-glycan branching complexity and sialylation with opportunities to generate tailored complex N-glycan structures on therapeutic glycoproteins in the future.",
keywords = "CHO, Erythropoietin, GNTIV/Mgat4, GNTV/Mgat5, N-glycosylation, Sialic acid",
author = "Bojiao Yin and Yuan Gao and Chung, {Cheng yu} and Shuang Yang and Emily Blake and Stuczynski, {Mark C.} and Juechun Tang and Kildegaard, {Helene F.} and Andersen, {Mikael R.} and Hui Zhang and Betenbaugh, {Michael J.}",
year = "2015",
month = "11",
day = "1",
doi = "10.1002/bit.25650",
language = "English (US)",
volume = "112",
pages = "2343--2351",
journal = "Biotechnology and Bioengineering",
issn = "0006-3592",
publisher = "Wiley-VCH Verlag",
number = "11",

}

TY - JOUR

T1 - Glycoengineering of Chinese hamster ovary cells for enhanced erythropoietin N-glycan branching and sialylation

AU - Yin, Bojiao

AU - Gao, Yuan

AU - Chung, Cheng yu

AU - Yang, Shuang

AU - Blake, Emily

AU - Stuczynski, Mark C.

AU - Tang, Juechun

AU - Kildegaard, Helene F.

AU - Andersen, Mikael R.

AU - Zhang, Hui

AU - Betenbaugh, Michael J.

PY - 2015/11/1

Y1 - 2015/11/1

N2 - Sialic acid, a terminal residue on complex N-glycans, and branching or antennarity can play key roles in both the biological activity and circulatory lifetime of recombinant glycoproteins of therapeutic interest. In order to examine the impact of glycosyltransferase expression on the N-glycosylation of recombinant erythropoietin (rEPO), a human α2,6-sialyltransferase (ST6Gal1) was expressed in Chinese hamster ovary (CHO-K1) cells. Sialylation increased on both EPO and CHO cellular proteins as observed by SNA lectin analysis, and HPLC profiling revealed that the sialic acid content of total glycans on EPO increased by 26%. The increase in sialic acid content was further verified by detailed profiling of the N-glycan structures using mass spectra (MS) analysis. In order to enhance antennarity/branching, UDP-N-acetylglucosamine: α-1,3-D-mannoside β1,4-N-acetylglucosaminyltransferase (GnTIV/Mgat4) and UDP-N-acetylglucosamine:α-1,6-D-mannoside β1,6-N-acetylglucosaminyltransferase (GnTV/Mgat5), was incorporated into CHO-K1 together with ST6Gal1. Tri- and tetraantennary N-glycans represented approximately 92% of the total N-glycans on the resulting EPO as measured using MS analysis. Furthermore, sialic acid content of rEPO from these engineered cells was increased ∼45% higher with tetra-sialylation accounting for ∼10% of total sugar chains compared to ∼3% for the wild-type parental CHO-K1. In this way, coordinated overexpression of these three glycosyltransferases for the first time in model CHO-K1 cell lines provides a mean for enhancing both N-glycan branching complexity and sialylation with opportunities to generate tailored complex N-glycan structures on therapeutic glycoproteins in the future.

AB - Sialic acid, a terminal residue on complex N-glycans, and branching or antennarity can play key roles in both the biological activity and circulatory lifetime of recombinant glycoproteins of therapeutic interest. In order to examine the impact of glycosyltransferase expression on the N-glycosylation of recombinant erythropoietin (rEPO), a human α2,6-sialyltransferase (ST6Gal1) was expressed in Chinese hamster ovary (CHO-K1) cells. Sialylation increased on both EPO and CHO cellular proteins as observed by SNA lectin analysis, and HPLC profiling revealed that the sialic acid content of total glycans on EPO increased by 26%. The increase in sialic acid content was further verified by detailed profiling of the N-glycan structures using mass spectra (MS) analysis. In order to enhance antennarity/branching, UDP-N-acetylglucosamine: α-1,3-D-mannoside β1,4-N-acetylglucosaminyltransferase (GnTIV/Mgat4) and UDP-N-acetylglucosamine:α-1,6-D-mannoside β1,6-N-acetylglucosaminyltransferase (GnTV/Mgat5), was incorporated into CHO-K1 together with ST6Gal1. Tri- and tetraantennary N-glycans represented approximately 92% of the total N-glycans on the resulting EPO as measured using MS analysis. Furthermore, sialic acid content of rEPO from these engineered cells was increased ∼45% higher with tetra-sialylation accounting for ∼10% of total sugar chains compared to ∼3% for the wild-type parental CHO-K1. In this way, coordinated overexpression of these three glycosyltransferases for the first time in model CHO-K1 cell lines provides a mean for enhancing both N-glycan branching complexity and sialylation with opportunities to generate tailored complex N-glycan structures on therapeutic glycoproteins in the future.

KW - CHO

KW - Erythropoietin

KW - GNTIV/Mgat4

KW - GNTV/Mgat5

KW - N-glycosylation

KW - Sialic acid

UR - http://www.scopus.com/inward/record.url?scp=84942363838&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942363838&partnerID=8YFLogxK

U2 - 10.1002/bit.25650

DO - 10.1002/bit.25650

M3 - Article

C2 - 26154505

AN - SCOPUS:84942363838

VL - 112

SP - 2343

EP - 2351

JO - Biotechnology and Bioengineering

JF - Biotechnology and Bioengineering

SN - 0006-3592

IS - 11

ER -